scholarly article | Q13442814 |
P50 | author | Ruud Veldhuizen | Q60730440 |
P2093 | author name string | Jo Rae Wright | |
Brett A Thibodeaux | |||
Richard J O'Callaghan | |||
Jaret L Malloy | |||
P2860 | cites work | Expression and localization of lung surfactant protein A in human tissues | Q28207683 |
Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection | Q28284528 | ||
Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa | Q28492810 | ||
Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function | Q28493115 | ||
Surfactant Proteins A and D and Pulmonary Host Defense | Q30049091 | ||
Pseudomonas aeruginosa lipopolysaccharides and pathogenesis | Q30469943 | ||
Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa | Q34008850 | ||
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist | Q34019954 | ||
Collections and ficolins: humoral lectins of the innate immune defense | Q34169976 | ||
Pulsating bubble technique for evaluating pulmonary surfactant | Q36573848 | ||
Regulation of pulmonary surfactant secretion and clearance | Q37739420 | ||
Secretion of extracellular proteins by Pseudomonas aeruginosa | Q37821408 | ||
Human surfactant protein B: structure, function, regulation, and genetic disease | Q40370763 | ||
Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus | Q40579448 | ||
Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase | Q41322766 | ||
Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity | Q42834889 | ||
Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs | Q43606169 | ||
Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. | Q44374316 | ||
Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain | Q44840275 | ||
Pulmonary surfactant: functions and molecular composition. | Q46027561 | ||
Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubble | Q46063626 | ||
Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection. | Q51659562 | ||
P433 | issue | 2 | |
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
P304 | page(s) | L409-18 | |
P577 | publication date | 2004-10-29 | |
P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
P1476 | title | Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions | |
P478 | volume | 288 |
Q39384774 | A Pseudomonas aeruginosa-secreted protease modulates host intrinsic immune responses, but how? |
Q34695043 | A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing |
Q45856453 | Adenoviral gene transfer of a mutant surfactant enzyme ameliorates pseudomonas-induced lung injury. |
Q54970130 | Airway Epithelium Dysfunction in Cystic Fibrosis and COPD. |
Q21131225 | An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity |
Q37418480 | An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease |
Q37814698 | Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). |
Q42029143 | Changes in Galleria mellonella lysozyme level and activity during Pseudomonas aeruginosa infection. |
Q44044915 | Chronic Pseudomonas aeruginosa infection reduces surfactant levels by inhibiting its biosynthesis. |
Q41891809 | Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. |
Q35687472 | Evidence for Autoinduction and Quorum Sensing in White Band Disease-Causing Microbes on Acropora cervicornis |
Q34871061 | Evolution of Pseudomonas aeruginosa virulence as a result of phage predation. |
Q39421726 | Evolution of surfactant protein-D levels in children with ventilator-associated pneumonia |
Q38136000 | Failure of respiratory defenses in the pathogenesis of bacterial pneumonia of cattle. |
Q30414550 | Genes required for and effects of alginate overproduction induced by growth of Pseudomonas aeruginosa on Pseudomonas isolation agar supplemented with ammonium metavanadate |
Q41886610 | Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media |
Q37837985 | IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates |
Q36567361 | Infectious keratitis: secreted bacterial proteins that mediate corneal damage |
Q35566398 | Innate immune responses to Pseudomonas aeruginosa infection. |
Q98882243 | Interactions of particulate matter and pulmonary surfactant: Implications for human health |
Q36895297 | Life at the front: dissecting bacterial-host interactions at the ocular surface. |
Q92026612 | Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model |
Q60922656 | Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor |
Q27001070 | Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung |
Q40251529 | Proapoptotic effects of P. aeruginosa involve inhibition of surfactant phosphatidylcholine synthesis |
Q24607872 | Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions |
Q38021378 | Proteases, cystic fibrosis and the epithelial sodium channel (ENaC). |
Q35784995 | Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection |
Q92825829 | Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators |
Q55296887 | Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease. |
Q40477924 | Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. |
Q36784102 | Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor |
Q33405478 | Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells |
Q38101888 | Pseudomonas aeruginosa: new insights into pathogenesis and host defenses |
Q33890598 | Recombinant expression and functional analysis of proteases from Streptococcus pneumoniae, Bacillus anthracis, and Yersinia pestis |
Q24815739 | Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients. |
Q33736033 | Single step concomitant concentration, purification and characterization of two families of lipopeptides of marine origin. |
Q55269439 | Surfactant Protein D in Respiratory and Non-Respiratory Diseases. |
Q28395117 | Surfactant and its role in the pathobiology of pulmonary infection |
Q36163103 | The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation |
Q34594227 | The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing |
Q26865690 | The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections |
Q33924226 | The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury. |
Q33288960 | The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A. |
Q37293867 | Therapeutic use of surfactant components in allergic asthma |
Search more.